The incorporation of the 3HP regimen for tuberculosis preventive treatment in the Brazilian health system: a secondary-database nationwide analysis

Bibliographic Details
Title: The incorporation of the 3HP regimen for tuberculosis preventive treatment in the Brazilian health system: a secondary-database nationwide analysis
Authors: Luiz Villarinho Pereira Mendes, Anete Trajman, Mônica Rodrigues Campos, Marilena Cordeiro Dias Villela Correa, Claudia Garcia Serpa Osorio-de-Castro
Source: Frontiers in Medicine, Vol 10 (2024)
Publisher Information: Frontiers Media S.A., 2024.
Publication Year: 2024
Collection: LCC:Medicine (General)
Subject Terms: Brazil, tuberculosis, latent tuberculosis, latent tuberculosis infection, drug utilization studies, Rifapentine, Medicine (General), R5-920
More Details: IntroductionThe recommendation of rifampin-based shorter - and safer – regimens for tuberculosis preventive treatment (TPT) is progressively replacing monotherapy with isoniazid by different countries. The Brazilian Ministry of Health (MoH) approved the incorporation of the Rifapentine + isoniazid regimen (3HP) at the end of 2020, with free distribution in the Brazilian Unified Health System (SUS) started from the last quarter of 2021. The objectives were to describe the implementation of the IL-TB System (Information System of TPT Notification) and uptake of Rifapentine + isoniazid (3HP) and Isoniazid (6H or 9H) in Brazil.MethodsA quantitative observational and descriptive was performed using the IL-TB National System as the main data source, from January 2018 to December 2022.Results and discussionThere was a steady increase of the number of TPT prescription quarterly throughout the period, which reflects the implementation of the system itself and the progressive adherence of the health system to the non-compulsory notification of new TPT. The substitution of isoniazid (6H or 9H) by 3HP is progressing. The 3HP regimen represented less than 4% of the total administered by the end of 2021, reaching around 30% in the second half of 2022 and 40% in the last quarters of 2022. The study points not only to the need to expand TPT in the country, but also to accelerate 3HP uptake and to encourage the municipalities to notify to the IL-TB system, since there is still a high level of underreporting.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2296-858X
Relation: https://www.frontiersin.org/articles/10.3389/fmed.2023.1289298/full; https://doaj.org/toc/2296-858X
DOI: 10.3389/fmed.2023.1289298
Access URL: https://doaj.org/article/a77709e6e8ee4123bbb4be0f0f0ae9bf
Accession Number: edsdoj.77709e6e8ee4123bbb4be0f0f0ae9bf
Database: Directory of Open Access Journals
More Details
ISSN:2296858X
DOI:10.3389/fmed.2023.1289298
Published in:Frontiers in Medicine
Language:English